|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.00 USD | +8.34% |
|
-5.86% | -47.65% |
| 04-10 | UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating | MT |
| 03-24 | QuidelOrtho Corporation Announces Chief Legal Officer Changes | CI |
Business description: QuidelOrtho Corporation
Number of employees: 6,500
Sales by Activity: QuidelOrtho Corporation
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Diagnostic Kits / Equipment | 1.7B | 3.27B | 3B | 2.78B | 2.73B |
Geographical breakdown of sales: QuidelOrtho Corporation
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
North America | - | 2.54B | 1.88B | 1.62B | 1.49B |
EMEA | - | 207M | 327M | 336M | 361M |
China | - | 220M | 310M | 325M | 335M |
JPAC | - | - | - | - | 293M |
Latin America | - | - | - | - | 253M |
Other | - | 303M | 483M | 502M | - |
Foreign | 283M | - | - | - | - |
United States | 1.42B | - | - | - | - |
Executive Committee: QuidelOrtho Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Blaser
CEO | Chief Executive Officer | 61 | 05/05/2024 |
Joseph Busky
DFI | Director of Finance/CFO | 58 | - |
Philip McLellan
COO | Chief Operating Officer | 57 | 14/11/2024 |
| Chief Tech/Sci/R&D Officer | - | 06/10/2024 | |
Patrick Klein
ADM | Chief Administrative Officer | - | 30/04/2022 |
Composition of the Board of Directors: QuidelOrtho Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Kenneth Buechler
CHM | Chairman | 72 | 10/12/2022 |
Evelyn Dilsaver
BRD | Director/Board Member | 71 | 31/12/2021 |
Mary Polan
BRD | Director/Board Member | 82 | 31/12/1992 |
Matthew Strobeck
BRD | Director/Board Member | 53 | 31/12/2017 |
Kenneth Widder
BRD | Director/Board Member | 73 | 31/12/2013 |
Joseph Wilkins
BRD | Director/Board Member | 64 | 31/12/2020 |
Edward Michael
BRD | Director/Board Member | 68 | 31/12/2017 |
Brian Blaser
BRD | Director/Board Member | 61 | 14/05/2024 |
John Chiminski
BRD | Director/Board Member | 62 | 05/12/2024 |
R. Huennekens
BRD | Director/Board Member | 61 | 05/12/2024 |
Company details: QuidelOrtho Corporation
Group companies: QuidelOrtho Corporation
| Name | Category and Sector |
|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions |
Medical Specialties
|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions |
Medical Specialties
|
Medical Diagnostic & Testing Equipment
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.34% | -5.86% | -45.20% | -83.33% | 943M | |
| +1.03% | +4.08% | +13.85% | -45.19% | 15.54B | |
| -2.21% | +0.61% | +79.72% | +86.72% | 2.23B | |
| +2.05% | +4.63% | -11.80% | +1.59% | 1.07B | |
| -0.67% | +1.30% | +3.27% | -44.89% | 786M | |
| -1.30% | -1.30% | -13.43% | -47.67% | 711M | |
| -6.52% | -2.86% | -23.34% | -55.57% | 613M | |
| +0.67% | +6.91% | +43.09% | -37.00% | 469M | |
| +1.17% | -4.75% | +225.22% | - | 465M | |
| -0.79% | -1.19% | -2.35% | -13.51% | 389M | |
| Average | +0.47% | -0.61% | +26.90% | -26.54% | 2.32B | |
| Weighted average by Cap. | +1.12% | +0.12% | +18.96% | -31.29% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QDEL Stock
- Company QuidelOrtho Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition